Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus (Q37144253)
Jump to navigation
Jump to search
scientific article published on April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus |
scientific article published on April 2008 |
Statements
1 reference
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus (English)
1 reference
Edward Mills
1 reference
Cecilia T Costiniuk
1 reference
Curtis L Cooper
1 reference
1 April 2008
1 reference
376-380
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference